Skip to main content
Anirban Mitra, MD, Urology, Los Angeles, CA

AnirbanMitraMDPhD

Urology • Los Angeles, CA

Minimally Invasive Surgery, Surgical Oncology

Urologic Oncologist, Cedars-Sinai Medical Center

Join to view full profile

Dr. Mitra is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Mitra's full profile

Already have an account?

  • Office

    8635 W Third St
    Ste 1070W
    Los Angeles, CA 90048
    Phone+1 310-423-4700
    Fax+1 310-423-4711

Summary

  • Anirban P. Mitra, MD, PhD, is a board-certified urologist and urologic oncologist at the Cedars-Sinai Urology Academic Practice. He is an Assistant Professor in the Departments of Urology and Computational Biomedicine at Cedars-Sinai Medical Center. Dr. Mitra's clinical practice includes treatment of cancers of the bladder, kidney, prostate, urethra, upper urinary tract, testis, penis and adrenal glands. He is fellowship-trained in the management of urologic malignancies, with expertise in complex open and minimally invasive (laparoscopic and robotic) surgery.

    Dr. Mitra's clinical work informs and directs his scientific interests. His research portfolio encompasses studies investigating clinicopathologic and molecular drivers of progression and therapeutic response of genitourinary tumors, with emphasis on urinary bladder cancer. His work has involved multidisciplinary collaborations, multicenter investigations and clinical trials, with an overarching goal of identifying optimal oncologic management strategies. His research has been published in high-impact journals and has been widely referenced. He has served on international advisory committees for urologic cancers and is on the editorial board for several journals.

Education & Training

  • KJ Somaiya Medical College
    KJ Somaiya Medical CollegeClass of 2002, Top 5% of graduating class
  • University of Southern California/Los Angeles General Medical Center (USC/LA General)
    University of Southern California/Los Angeles General Medical Center (USC/LA General)Residency, Urology
  • University of Texas M D Anderson Cancer Center
    University of Texas M D Anderson Cancer CenterFellowship, Urologic Surgical Oncology
  • University of Southern California
    University of Southern CaliforniaPhD, Pathobiology, J. Watumull Scholarship; Best PhD student

Certifications & Licensure

  • TX State Medical License
    TX State Medical License 2020 - 2026
  • CA State Medical License
    CA State Medical License 2017 - 2025
  • American Board of Urology Urology

Awards, Honors, & Recognition

  • Invited Committee Member, International Consultation on Molecular Biomarkers in Urologic Oncology International Consultation on Urologic Diseases (ICUD), World Urologic Oncology Federation (WUOF), Société Internationale d'Urologie (SIU)
  • Arnold Heyman Scholarship Institute of Urology, University of Southern California
  • Marquis Who's Who in the World
  • Join now to see all

Publications & Presentations

PubMed

Books/Book Chapters

  • Precision Molecular Pathology of Bladder Cancer 
    Chapter: Risk factors and molecular features associated with bladder cancer development. 
    Page 3 - 28Mitra AP, Bartsch G Jr, Cote RJEditors: Hansel DE, Lerner SP.Springer Nature, Cham, Switzerland2018
  • Bladder Cancer: A Joint SIU-ICUD International Consultation 
    Chapter: Molecular markers 
    Page 285 - 371Shariat SF, Lotan Y, Dobruch J, Gust KM, Inman BA, Krabbe LM, Mitra AP, Soria F, Todenhöfer TEditors: Black P, Gontero P.Société Internationale d’Urologie, Montréal, Canada2018
  • Prostate Cancer: A Multidisciplinary Approach to Diagnosis and Management 
    Chapter: Novel molecular and genotype profiling in prostate cancer: the future of screening, diagnosis, and staging. 
    Page 77 - 83Shin H, Vergara IA, Mitra AP, Triche TJ, Davicioni EEditors: Dicker AP, Kelly WK, Zaorsky NG, Trabulsi EJ.Demos Medical, New York, NY2015
  • Join now to see all

Authored Content

  • Molecular biology of bladder cancer.February 2020
  • US Patent # 8293880 - Prognostic panel for urinary bladder cancer.October 2012
  • Urine biomarkers for the detection of urothelial (transitional cell) carcinoma of the bladder.July 2009

Press Mentions

  • Pre-cystectomy smoking linked to worse outcomes after surgery.
    Pre-cystectomy smoking linked to worse outcomes after surgery.May 1st, 2020
  • Prolonged surgical delay increases bladder cancer recurrence risk.
    Prolonged surgical delay increases bladder cancer recurrence risk.May 1st, 2020
  • Smoking intensity and cancer markers predict seriousness of bladder cancer.
    Smoking intensity and cancer markers predict seriousness of bladder cancer.May 1st, 2020
  • Join now to see all

Other Languages

  • Hindi, Bengali

Dr. Anirban Mitra, Dr. Anirban Mitra, MD, Dr. A Mitra